GB9718791D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9718791D0
GB9718791D0 GBGB9718791.8A GB9718791A GB9718791D0 GB 9718791 D0 GB9718791 D0 GB 9718791D0 GB 9718791 A GB9718791 A GB 9718791A GB 9718791 D0 GB9718791 D0 GB 9718791D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9718791.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9718791.8A priority Critical patent/GB9718791D0/en
Publication of GB9718791D0 publication Critical patent/GB9718791D0/en
Priority to AU97408/98A priority patent/AU9740898A/en
Priority to PCT/EP1998/005560 priority patent/WO1999012545A2/en
Ceased legal-status Critical Current

Links

GBGB9718791.8A 1997-09-05 1997-09-05 Medicaments Ceased GB9718791D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9718791.8A GB9718791D0 (en) 1997-09-05 1997-09-05 Medicaments
AU97408/98A AU9740898A (en) 1997-09-05 1998-09-03 Medicaments containing acyclovir
PCT/EP1998/005560 WO1999012545A2 (en) 1997-09-05 1998-09-03 Medicaments containing acyclovir

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9718791.8A GB9718791D0 (en) 1997-09-05 1997-09-05 Medicaments

Publications (1)

Publication Number Publication Date
GB9718791D0 true GB9718791D0 (en) 1997-11-12

Family

ID=10818545

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9718791.8A Ceased GB9718791D0 (en) 1997-09-05 1997-09-05 Medicaments

Country Status (3)

Country Link
AU (1) AU9740898A (en)
GB (1) GB9718791D0 (en)
WO (1) WO1999012545A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211243B1 (en) * 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
FR2837102B1 (en) * 2002-03-18 2004-10-08 Palbian Snc AQUEOUS GEL COMPOSITION, MANUFACTURING METHOD AND USE FOR THE MANUFACTURE OF A MEDICAMENT, ESPECIALLY ANTIHERPETIC
US7666914B2 (en) * 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
WO2006012146A2 (en) * 2004-06-24 2006-02-02 Idexx Laboratories, Inc. Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US8771712B2 (en) * 2006-05-09 2014-07-08 Emisphere Technologies, Inc. Topical administration of acyclovir
FR2924024B1 (en) * 2007-11-27 2012-08-17 Centre Nat Rech Scient NANOPARTICLES OF THERAPEUTIC ACTIVE INGREDIENTS OF LOW AQUEOUS SOLUBILITY
JP4972062B2 (en) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ Antiviral preparation
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
US8846725B2 (en) 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Pharmaceutical compositions in semisolid form and a squeezable container for administration thereof
GB9408545D0 (en) * 1994-04-29 1994-06-22 Zyma Sa Compositions
DE4425322A1 (en) * 1994-07-18 1996-01-25 Merck Patent Gmbh Virostatics in a hydrophobic base for topical use
IT1275955B1 (en) * 1995-03-22 1997-10-24 Dompe Spa PHARMACEUTICAL FORMULATIONS IN THE FORM OF THISSOTROPIC GEL
WO1997034607A1 (en) * 1996-03-20 1997-09-25 Glaxo Group Limited Topical formulations of aciclovir

Also Published As

Publication number Publication date
WO1999012545A3 (en) 1999-06-10
WO1999012545A2 (en) 1999-03-18
AU9740898A (en) 1999-03-29

Similar Documents

Publication Publication Date Title
HUP0003750A3 (en) Medicaments
GB9606805D0 (en) Medicaments
GB9702021D0 (en) Medicaments
GB9718791D0 (en) Medicaments
GB9618974D0 (en) Medicaments
GB9611947D0 (en) Medicaments
GB9605293D0 (en) Medicaments
GB2320900B (en) Inhalers
GB9828620D0 (en) Medicaments
GB9611167D0 (en) Medicaments
GB9613096D0 (en) Medicaments
GB9723506D0 (en) Medicaments
GB9723061D0 (en) Medicaments
GB9703045D0 (en) Medicaments
GB9702132D0 (en) Medicaments
GB9700908D0 (en) Medicaments
GB9700323D0 (en) Combined medicaments
GB2329335B (en) Medicament
GB9726234D0 (en) Medicament
GB9702946D0 (en) Medicament
GB0002424D0 (en) Medicament
GB9605305D0 (en) Medicaments
GB9623160D0 (en) Medicaments
GB9605859D0 (en) Medicaments
GB9605329D0 (en) Medicaments

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)